Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Surgery Partners (SGRY) Consolidated Net Income: 2013-2024

Historic Consolidated Net Income for Surgery Partners (SGRY) over the last 11 years, with FY2024 value amounting to $12.5 million.

  • Surgery Partners' Consolidated Net Income rose 29531.25% to $25.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.3 million, marking a year-over-year decrease of 7797.73%. This contributed to the annual value of $12.5 million for FY2024, which is 9076.13% down from last year.
  • As of FY2024, Surgery Partners' Consolidated Net Income stood at $12.5 million, which was down 9076.13% from $135.3 million recorded in FY2023.
  • Surgery Partners' Consolidated Net Income's 5-year high stood at $135.3 million during FY2023, with a 5-year trough of $1.3 million in FY2020.
  • In the last 5 years, Surgery Partners' Consolidated Net Income had a median value of $70.7 million in 2021 and averaged $61.4 million.
  • In the last 5 years, Surgery Partners' Consolidated Net Income crashed by 9711.75% in 2020 and then soared by 533846.15% in 2021.
  • Surgery Partners' Consolidated Net Income (Annual) stood at $1.3 million in 2020, then surged by 5338.46% to $70.7 million in 2021, then increased by 23.06% to $87.0 million in 2022, then soared by 55.52% to $135.3 million in 2023, then plummeted by 90.76% to $12.5 million in 2024.
  • Its last three reported values are $12.5 million in FY2024, $135.3 million for FY2023, and $87.0 million during FY2022.